Study Tracks Physical and Cognitive Impairments Associated with Long COVID
PLOS
Researchers following nearly 1,000 people with post-COVID-19 syndrome found few changes to their symptoms in the second year of illness
Pandemic
New Software Flags Emergence of COVID-19 Variants
American Museum of Natural History
New surveillance technique could be used in future pandemics
The State of Clinical Development in 2023
Gen Li, PhD, MBA
Increasing Phase 2 clinical trial cancellations can have a long-drawn and multifold impact on clinical research
Monocyte Count Predicts Lung Disease Risk in COVID-19 Patients
University of Virginia Health System
A simple blood test result can inform clinicians which patients with severe COVID-19 will develop long-haul lung problems
Treatments for Long COVID-Related Neurological Symptoms in Trials
National Institutes of Health
Trials will test at least three treatments for long COVID symptoms, such as fast heart rate, dizziness, and fatigue
Lingering IFN-γ May Be Responsible for Long COVID Symptoms
University of Cambridge
High levels of IFN-γ persisted in some long COVID patients for up to 31 months, making it a reliable biomarker
Vaccination During Pregnancy Protects Newborns from COVID-19
National Institutes of Health
Maternal antibodies elicited by COVID-19 vaccine and booster doses were identified in infants’ cord blood
COVID-19 Vaccine Lowers Mortality in Newborns of Vaccinated Women
Karolinska Institutet
Results are from the largest study to date on the safety of newborns whose mothers were vaccinated against COVID-19 during pregnancy
Overlapping Epitopes to Develop Safe, Better-Suited Vaccines
Heinrich Heine University Düsseldorf
Epitopes are an alternative to mRNA and may elicit targeted immune responses quickly, cost-effectively, and safely
Measles Remains a Global Threat as Vaccination Coverage Declines
Centers for Disease Control and Prevention
Millions of children missed vaccinations during the COVID-19 pandemic, driving up the global number of cases